Shrestha, Dhan BahadurSedhai, Yub RajDawadi, SagunDhakal, BishalShtembari, JurgenSingh, KaranAcharya, RoshanBasnyat, SoneyWaheed, IrfanKhan, Mohammad SaudKazimuddin, MohammedPatel, Nimesh K.Kalahasty, GauthamBhave, Prashant DattatrayaWhalen, PatrickShantha, Ghanshyam2023-04-122023-04-122023-04-10Shrestha, D.B.; Sedhai, Y.R.; Dawadi, S.; Dhakal, B.; Shtembari, J.; Singh, K.; Acharya, R.; Basnyat, S.; Waheed, I.; Khan, M.S.; Kazimuddin, M.; Patel, N.K.; Kalahasty, G.; Bhave, P.D.; Whalen, P.; Shantha, G. Outcome of In-Hospital Cardiac Arrest among Patients with COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2023, 12, 2796.http://hdl.handle.net/10919/114488Background: Outcomes following in-hospital cardiac arrest (IHCA) in patients with COVID-19 have been reported by several small single-institutional studies; however, there are no large studies contrasting COVID-19 IHCA with non-COVID-19 IHCA. The objective of this study was to compare the outcomes following IHCA between COVID-19 and non-COVID-19 patients. Methods: We searched databases using predefined search terms and appropriate Boolean operators. All the relevant articles published till August 2022 were included in the analyses. The systematic review and meta-analysis were conducted as per Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. An odds ratio with a 95% confidence interval (CI) was used to measure effects. Results: Among 855 studies screened, 6 studies with 27,453 IHCA patients (63.84% male) with COVID-19 and 20,766 (59.7% male) without COVID-19 were included in the analysis. IHCA among patients with COVID-19 has lower odds of achieving return of spontaneous circulation (ROSC) (OR: 0.66, 95% CI: 0.62–0.70). Similarly, patients with COVID-19 have higher odds of 30-day mortality following IHCA (OR: 2.26, 95% CI: 2.08–2.45) and have 45% lower odds of cardiac arrest because of a shockable rhythm (OR: 0.55, 95% CI: 0.50–0.60) (9.59% vs. 16.39%). COVID-19 patients less commonly underwent targeted temperature management (TTM) or coronary angiography; however, they were more commonly intubated and on vasopressor therapy as compared to patients who did not have a COVID-19 infection. Conclusions: This meta-analysis showed that IHCA with COVID-19 has a higher mortality and lower rates of ROSC compared with non-COVID-19 IHCA. COVID-19 is an independent risk factor for poor outcomes in IHCA patients.application/pdfenCreative Commons Attribution 4.0 InternationalCOVID-19in-hospital cardiac arrestmortalityArticle - Refereed2023-04-12https://doi.org/10.3390/jcm12082796